Acquisition Leverage Since Boston Scientific acquired Symetis in 2017, there is an opportunity to promote integrated product solutions such as the ACURATE neo Valve System, which benefits from the combined expertise and distribution channels of both companies.

Innovation Focus Recent investments in minimally-invasive medical technologies at the Cork facility highlight ongoing innovation efforts, presenting a chance to position new or complementary technologies that align with Boston Scientific's development pipeline.

Targeted Partnerships Partnerships like the collaboration with the Sickle Cell Society emphasize a focus on raising awareness and addressing specific medical needs, opening avenues for targeted solutions or educational programs that can enhance market reach.

Market Expansion With a global footprint and recent investments in manufacturing assets, there is potential to expand distribution and sales in emerging markets or underserved regions for cardiovascular and minimally-invasive devices.

Customer Engagement Leadership in progressive medical systems offers opportunities to engage healthcare providers and hospitals with tailored demonstrations, training, and support services to grow adoption of Symetis's innovative valve systems and related tech.